FDA-2024-0021-V121

Type IA variation for application FDA-2024-0021. Type IA variation: Specification Change for Kcluximab — minor update

Variation Number
FDA-2024-0021-V121
Type
Type IA
Application
FDA-2024-0021
Change
CHG-2024-0121
Status
Approved
Fee
€846
Submitted
—
Approved
2023-12-23
Description

Type IA variation: Specification Change for Kcluximab — minor update